A review of sunscreen safety and efficacy

被引:0
|
作者
Gasparro, FP [1 ]
Mitchnick, M
Nash, JF
机构
[1] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA
[2] SunSmart Inc, Wainscott, NY USA
[3] Procter & Gamble Co, Cincinnati, OH USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of sunscreen products has been advocated by many health care practitioners as a means to reduce skin damage produced by ultraviolet radiation (UVR) from sunlight. There is a need to better understand the efficacy and safety of sunscreen products given this ongoing campaign encouraging their use. The approach used to establish sunscreen efficacy, sun protection factor (SPF), is a useful assessment of primarily UVB (290-320 nm) filters. The SPF test, however, does not adequately assess the complete photoprotective profile of sunscreens specifically against long wavelength UVAI (340-400 nm), Moreover, to date, there is no singular, agreed upon method for evaluating UVA efficacy despite the immediate and seemingly urgent consumer need to develop sunscreen products that provide broad-spectrum UVB and UVA photoprotection, With regard to the safety of UVB and UVA filters, the current list of commonly used organic and inorganic sunscreens has favorable toxicological profiles based on acute, subchronic and chronic animal or human studies. Further, in most studies, sunscreens have been shown to prevent the damaging effects of UVR exposure, Thus, based on this review of currently available data, it is concluded that sunscreen ingredients or products do not pose a human health concern. Further, the regular use of appropriate broad-spectrum sunscreen products could have a significant and favorable impact on public health as part of an overall strategy to reduce UVR exposure.
引用
收藏
页码:243 / 256
页数:14
相关论文
共 50 条
  • [41] Dapagliflozin efficacy and safety: a perspective review
    Anderson, Sarah L.
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2014, 5 (06) : 242 - 254
  • [42] Efficacy of sunscreen in preventing nevi - Reply
    Gallagher, RP
    Bajdik, CD
    Lee, TK
    Rivers, JK
    McLean, DI
    Coldman, AJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (22): : 2870 - 2870
  • [43] EFFECT OF FILM IRREGULARITIES ON SUNSCREEN EFFICACY
    ONEILL, JJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (07) : 888 - 891
  • [44] Enhancing sunscreen efficacy in the 'real' world?
    Jungman, E.
    Maibach, H. I.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2010, 21 (05) : 261 - 266
  • [45] SAFETY AND EFFICACY OF A BROAD-SPECTRUM SUNSCREEN IN PATIENTS WITH DISCOID OR SUBACUTE CUTANEOUS LUPUS-ERYTHEMATOSUS
    CALLEN, JP
    ROTH, DE
    MCGRATH, C
    DROMGOOLE, SH
    [J]. CUTIS, 1991, 47 (02): : 130 - &
  • [46] Sunscreen Application, Safety, and Sun Protection: The Evidence
    Li, Heidi
    Colantonio, Sophia
    Dawson, Andrea
    Lin, Xing
    Beecker, Jennifer
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2019, 23 (04) : 357 - 369
  • [47] Duration of efficacy for daily facial sunscreen product
    Nash, J. F.
    Tanner, Paul
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB225 - AB225
  • [48] A review of the safety and efficacy of lufenuron in dogs and cats
    Stansfield, DG
    [J]. CANINE PRACTICE, 1997, 22 (2-3) : 34 - 38
  • [49] Efficacy and safety of novel antipsychotics: A critical review
    Balestrieri, M
    Vampini, C
    Bellantuono, C
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2000, 15 (07) : 499 - 512
  • [50] Comparative efficacy and safety of basal insulins: A review
    Vargas-Uricoechea, Hernando
    Aschner, Pablo
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (06)